Exicure's Significant Pre-Market Uptick Among Various Stocks on the Move

In a notable pre-market trading session, shares of Exicure, Inc. XCUR, a Chicago-based clinical-stage biotechnology company, surged by 49.3% to $2.39. This significant leap followed the company's announcement of debt-for-equity exchange agreements that have enabled it to regain compliance with Nasdaq listing requirements. Exicure's rise in the stock market is a reflection of its ongoing development of therapies using its proprietary spherical nucleic acid (SNA) technology, aimed at treating an array of diseases including neurology and immuno-oncology.

Other Stocks Gaining Momentum in Pre-Market Trading

Apart from Exicure, several other stocks are making moves in today's pre-market trading. Guardant Health, Inc. GH, a leader in precision oncology with its blood tests and data sets, is headquartered in Redwood City, California, and is one to watch. Entero Therapeutics, Inc. ENTO, focusing on gastrointestinal diseases from Boca Raton, Florida; Edgio, Inc. EGIO, a content delivery network from Tempe, Arizona; and Universe Pharmaceuticals INC UPC, a traditional Chinese medicine corporation in China, are also on the radar.

Moreover, stocks like NuCana plc NCNA, involved in cancer treatment developments in the UK; Iteos Therapeutics, Inc. ITOS, an immuno-oncology company from Cambridge, Massachusetts; Yunji Inc. YJ, operating a social e-commerce platform in China; and Protagenic Therapeutics, Inc. PTIX, focusing on stress-related disorders from New York, are active in the pre-market session.

Other notable movers include Adagene Inc. ADAG, a cancer therapy firm in Suzhou, China; Purple Biotech Ltd. PPBT, a US-based pharma company; Rafael Holdings, Inc. RFL, with real estate and pharmaceutical interests; Tenon Medical, Inc. TNON, a medical device company in California; and SMX (Security Matters) Public Limited Company SMX, a tracking technologies developer in Australia.

Exicure, Stocks, PreMarket